Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2.
Merimsky O, Gez E, Weitzen R, Nehushtan H, Rubinov R, Hayat H, Peretz T, Ben-Shahar M, Biran H, Katsenelson R, Mermershtein V, Loven D, Karminsky N, Neumann A, Matcejevsky D, Inbar M. Merimsky O, et al. Among authors: peretz t. Ann Oncol. 2004 Apr;15(4):610-2. doi: 10.1093/annonc/mdh137. Ann Oncol. 2004. PMID: 15033668 Free article. Clinical Trial.
Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on Cancer.
Lotem M, Peretz T, Drize O, Gimmon Z, Ad El D, Weitzen R, Goldberg H, Ben David I, Prus D, Hamburger T, Shiloni E. Lotem M, et al. Among authors: peretz t. Br J Cancer. 2002 May 20;86(10):1534-9. doi: 10.1038/sj.bjc.6600251. Br J Cancer. 2002. PMID: 12085200 Free PMC article. Clinical Trial.
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: results by demographic and clinical subgroups.
Ron IG, Wigler N, Borovik R, Peretz T, Rizel S, Shani A, Brenner J, Farbstein H, Brenner HJ, Chaitchik S, Catane R, Inbar MJ. Ron IG, et al. Among authors: peretz t. Am J Clin Oncol. 2002 Oct;25(5):520-2. doi: 10.1097/00000421-200210000-00020. Am J Clin Oncol. 2002. PMID: 12393997 Clinical Trial.
Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival.
Nisman B, Biran H, Heching N, Barak V, Ramu N, Nemirovsky I, Peretz T. Nisman B, et al. Among authors: peretz t. Br J Cancer. 2008 Jan 15;98(1):77-9. doi: 10.1038/sj.bjc.6604157. Epub 2007 Dec 18. Br J Cancer. 2008. PMID: 18087272 Free PMC article.
Gemcitabine in combination with paclitaxel for advanced soft-tissue sarcomas.
Sonnenblick A, Eleyan F, Peretz T, Ospovat I, Merimsky O, Sella T, Peylan-Ramu N, Katz D. Sonnenblick A, et al. Among authors: peretz t. Mol Clin Oncol. 2015 Jul;3(4):829-832. doi: 10.3892/mco.2015.545. Epub 2015 Apr 16. Mol Clin Oncol. 2015. PMID: 26171190 Free PMC article.
327 results